← Browse by Condition

Medical Condition

lung cancer

Total Trials

65

Recruiting Now

65

Trial Phases

Phase 2, Phase 1, Phase 3

Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer

University of California, San ...

Empathic Communication Skills (ECS) Training

Memorial Sloan Kettering Cance...

NCT05849129 Phase 2

Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer

The Canadian College of Naturo...

To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer

Singlera Genomics Inc.

NCT07260591 Phase 1

VSV-02 Compassionate Use in Advanced Solid Tumors

The First Affiliated Hospital ...

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

Instituto Nacional de Cancerol...

NCT06229340 Phase 2

Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations

N.N. Petrov National Medical R...

NCT06010862 Phase 1

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Chongqing Precision Biotech Co...

The Effect of Immersive Virtual Reality and Relaxing Videos on Lung Cancer Patients

Turkey (Türkiye)

Hacettepe University

A Registry for People With Lung Cancer

United States, Canad...

Memorial Sloan Kettering Cance...

Comparison Between Endovascular and Bronchoscopic Tumor Marker Insertion for Real-time Stereotactic-guided Radiotherapy in Lung Cancer

Centre Hospitalier Universitai...

Comprehensive Outcomes for After Cancer Health

NCT05452005 Phase 1

Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer

University of California, Davi...

99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

Nanjing First Hospital, Nanjin...

Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy

NCT06749886 Phase 2

An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting

Shanghai Pulmonary Hospital, S...

Avecure Flexible Microwave Ablation Probe For Lung Nodules

Beth Israel Deaconess Medical ...

Prevention of Smoking Related Diseases

Scientific Institute San Raffa...

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

United States, Austr...

NCT05669586 Phase 2

Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer

Affiliated Hospital of Jiangna...

Assessment System of Sarcopenia in Lung Cancer Patients

West China Hospital

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

Vanderbilt-Ingram Cancer Cente...

Lung Cancer Screening in High-risk Black Individuals

Massachusetts General Hospital

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Patient-Reported Outcomes

The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person

Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer

Massachusetts General Hospital

Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study

Shanghai Pulmonary Hospital, S...

Patient-derived Organoids of Lung Cancer to Test Drug Response

University Hospital, Geneva

Lung Cancer Registry

Arbeitsgemeinschaft medikament...

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

Wake Forest University Health ...

NCT06607796 Phase 3

Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy

Curatively Intended Thoracic Reirradiation

University of Aarhus

NCT07181720 Phase 1

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Chongqing Precision Biotech Co...

NCT06508307 Phase 1

A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors

GONGCHU Biotechnology Co., Ltd

Healthy Homes Study

Dartmouth-Hitchcock Medical Ce...

NCT06381960 Phase 2

Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Cancer by Fuzheng Quxie Recipe

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

Dana-Farber Cancer Institute

Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes

M.D. Anderson Cancer Center

Virtual Agent Feasibility in Oncology Patients (NTT Data)

Duke University

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Hospices Civils de Lyon

NCT06580002 Phase 2

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

University of California, Irvi...

NCT05633667 Phase 2

Study of Novel Treatment Combinations in Patients With Lung Cancer

United States, Brazi...

Gilead Sciences

NCT07241767 Phase 2

A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer

Jiangsu HengRui Medicine Co., ...

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

Brigham and Women's Hospital

Lung Cancer Biomarkers and Screening

NYU Langone Health

Piloting a Virtual Navigation (VN) System for Bronchoscopic Lung Nodule Sampling

Penn State University

Detection of Genetic Markers of Lung Cancer

University of Pittsburgh

Virtual Personalized Exercise Program for Lung Cancer Patients

Northwell Health

NCT06646471 Phase 4

PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies

GFPC Investigation

NCT04459065 Phase 1, Phase 2

Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery

University of Saskatchewan

NCT06810544 Phase 1, Phase 2

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Tango Therapeutics, Inc.

Analysis of Screen-detected Lung Cancers' Genomic Traits

University College, London

NCT05525338 Phase 4

Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels

France, Netherlands

University Medical Center Gron...

NCT05358548 Phase 2

ATATcH Alternating Treatment Plans for Advanced Cancer

Rutgers, The State University ...

Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway

Assistance Publique Hopitaux D...

Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

University of Texas Southweste...

A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients

The University of Hong Kong

NCT04585750 Phase 1, Phase 2

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

United States, Austr...

PMV Pharmaceuticals, Inc

Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy

Centre Hospitalier Universitai...

NCT06478108 Phase 2, Phase 3

Interventional Software for Multi-immunotherapy of Solid Tumors

Second Affiliated Hospital of ...

Improving Care for Rural Patients With Solid Tumors

University of Colorado, Denver

The Florida ASCENT Study

University of Florida

Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules

Hasselt University

NCT06307249 Phase 1

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Lebanese University